ABI2 and nasopharyngeal carcinoma: Even though miR-BART13-3p had a lower prognostic value than miR-BART7-3p in NPC patients, two studies conducted in vitro and in vivo have revealed that miR-BART13-3p can enhance the NPC cells metastasis by decreasing the expression of Abl interactor 2 (ABI2) and NF-κB inhibitor interacting Ras-like 2 (NKIRAS2) and the pro-apoptotic protein caprin family member 2 (CAPRIN2) [40, 96, 97].